Eric Delaporte

Q: What Schools Are Affiliated With Eric Delaporte

Eric Delaporte is affiliated with the following schools: University of California, Berkeley, University of Nottingham, University of Montpellier, Stanford University, University of Alabama at Birmingham

Eric Delaporte's AcademicInfluence.com Rankings

Eric Delaporte

Computer Science

#9002

World Rank

#9460

Historical Rank

Artificial Intelligence

#4155

World Rank

#4213

Historical Rank

Database

#5996

World Rank

#6217

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Eric Delaporte's Degrees

PhD Computer Science Stanford University
Masters Artificial Intelligence University of California, Berkeley

Similar Degrees You Can Earn

Why Is Eric Delaporte Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Eric Delaporte's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1 (2006) (912)
Origin of the human malaria parasite Plasmodium falciparum in gorillas (2010) (509)
Human immunodeficiency viruses: SIV infection in wild gorillas (2006) (384)
Unprecedented Degree of Human Immunodeficiency Virus Type 1 (HIV-1) Group M Genetic Diversity in the Democratic Republic of Congo Suggests that the HIV-1 Pandemic Originated in Central Africa (2000) (342)
Antigenic conservation and immunogenicity of the HIV coreceptor binding site (2005) (316)
Risk to Human Health from a Plethora of Simian Immunodeficiency Viruses in Primate Bushmeat (2002) (307)
The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study (2002) (305)
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial (2004) (304)
Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study (2006) (295)
Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. (1989) (262)
African great apes are natural hosts of multiple related malaria species, including Plasmodium falciparum (2010) (230)
Adherence to HAART and its principal determinants in a cohort of Senegalese adults (2003) (212)
Geographical distribution of HIV‐1 group O viruses in Africa (1997) (209)
Genetic Diversity of Protease and Reverse Transcriptase Sequences in Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains: Evidence of Many Minor Drug Resistance Mutations in Treatment-Naive Patients (2000) (194)
African origin of the malaria parasite Plasmodium vivax (2014) (186)
Long-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults (2005) (184)
Dating the common ancestor of SIVcpz and HIV‐1 group M and the origin of HIV‐1 subtypes by using a new method to uncover clock‐like molecular evolution (2001) (159)
Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes. (1994) (156)
Origin of the HIV-1 group O epidemic in western lowland gorillas (2015) (155)
Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies (1997) (147)
Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon. (2007) (146)
Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses. (1999) (145)
Efficiencies of Four Versions of the AMPLICOR HIV-1 MONITOR Test for Quantification of Different Subtypes of Human Immunodeficiency Virus Type 1 (1999) (137)
Characterization of a Novel Simian Immunodeficiency Virus with a vpu Gene from Greater Spot-Nosed Monkeys (Cercopithecus nictitans) Provides New Insights into Simian/Human Immunodeficiency Virus Phylogeny (2002) (136)
Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. (2019) (135)
Characterization of a Highly Replicative Intergroup M/O Human Immunodeficiency Virus Type 1 Recombinant Isolated from a Cameroonian Patient (1999) (130)
Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. (2000) (119)
Presence of multiple non‐B subtypes and divergent subtype B strains of HIV‐1 in individuals infected after overseas deployment (1997) (117)
New Simian Immunodeficiency Virus Infecting De Brazza's Monkeys (Cercopithecus neglectus): Evidence for a Cercopithecus Monkey Virus Clade (2004) (116)
Prevalence of intestinal parasites including microsporidia in human immunodeficiency virus-infected adults in Cameroon: a cross-sectional study. (2006) (114)
Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma (1996) (114)
Characterization of a Novel Simian Immunodeficiency Virus from Guereza Colobus Monkeys (Colobus guereza) in Cameroon: a New Lineage in the Nonhuman Primate Lentivirus Family (2001) (111)
Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). (1994) (107)
Genetic and phylogenetic analysis of env subtypes G and H in central Africa. (1994) (106)
Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. (2011) (105)
Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions. (2010) (105)
Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage. (2003) (104)
Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal (2003) (101)
Hepatitis B, C seroprevalence and delta viruses in HIV‐1 Senegalese patients at HAART initiation (retrospective study) (2008) (101)
Evaluation of Different RNA Extraction Methods and Storage Conditions of Dried Plasma or Blood Spots for Human Immunodeficiency Virus Type 1 RNA Quantification and PCR Amplification for Drug Resistance Testing (2009) (100)
Two new human T-lymphotropic virus type I phylogenetic subtypes in seroindeterminates, a Mbuti pygmy and a Gabonese, have closest relatives among African STLV-I strains. (1998) (98)
Molecular Epidemiology of Simian Immunodeficiency Virus Infection in Wild-Living Gorillas (2009) (98)
Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. (2000) (97)
Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations. (1989) (96)
Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. (2001) (96)
Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia. (2014) (94)
Identification of a New Simian Immunodeficiency Virus Lineage with a vpu Gene Present among Different Cercopithecus Monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon (2003) (94)
Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study. (2017) (94)
Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon (2009) (93)
High diversity of HIV-1 subtype F strains in Central Africa. (1999) (87)
Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution. (2000) (87)
Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994. (1996) (85)
Widespread Infection with Homologues of Human Parvoviruses B19, PARV4, and Human Bocavirus of Chimpanzees and Gorillas in the Wild (2010) (83)
Use of a generic polymerase chain reaction assay detecting human T‐lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology (1997) (82)
Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution. (2001) (80)
Distribution of HIV-1 Variants in the Democratic Republic of Congo Suggests Increase of Subtype C in Kinshasa Between 1997 and 2002 (2005) (79)
Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients (2011) (78)
Genetic subtypes of HIV type 1 and HIV type 2 strains in commercial sex workers from Bamako, Mali. (1998) (77)
Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence. (2000) (77)
Resistance to Antiretroviral Treatment in Gabon: Need for Implementation of Guidelines on Antiretroviral Therapy Use and HIV‐1 Drug Resistance Monitoring in Developing Countries (2002) (75)
New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors. (2016) (74)
Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping. (2010) (74)
Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence. (1999) (73)
Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients. (2006) (73)
Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Côte d’Ivoire (2013) (72)
Origin and diversity of human retroviruses. (2014) (70)
Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years. (1996) (70)
Depressive symptoms among survivors of Ebola virus disease in Conakry (Guinea): preliminary results of the PostEboGui cohort (2017) (69)
No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study. (2002) (69)
Lipodystrophy and Metabolic Disorders in HIV-1-Infected Adults on 4- to 9-Year Antiretroviral Therapy in Senegal: A Case-Control Study (2009) (69)
HIV-1 Drug-Resistance Mutations among Newly Diagnosed Patients before Scaling-Up Programmes in Burkina Faso and Cameroon (2005) (69)
Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'Ivoire (1992) (68)
Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. (2009) (68)
Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms (2011) (67)
Simian T-Cell Leukemia Virus (STLV) Infection in Wild Primate Populations in Cameroon: Evidence for Dual STLV Type 1 and Type 3 Infection in Agile Mangabeys (Cercocebus agilis) (2004) (67)
Detection and Genetic Characterization of Enteroviruses Circulating among Wild Populations of Chimpanzees in Cameroon: Relationship with Human and Simian Enteroviruses (2011) (65)
Epidemiology of HTLV‐i in gabon (western equatorial Africa) (1988) (64)
Prevalence of HIV and other sexually transmitted infections, and risk behaviours in unregistered sex workers in Dakar, Senegal (2003) (64)
High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo (2016) (64)
Field Evaluation of Dried Blood Spots for Routine HIV-1 Viral Load and Drug Resistance Monitoring in Patients Receiving Antiretroviral Therapy in Africa and Asia (2013) (63)
Access to antiretroviral drugs and AIDS management in Senegal (2003) (62)
Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries (2008) (61)
Plasmodium falciparum-like parasites infecting wild apes in southern Cameroon do not represent a recurrent source of human malaria (2013) (60)
Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients. (2006) (60)
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. (2017) (60)
Low rate of genotypic HIV‐1 drug‐resistant strains in the Senegalese government initiative of access to antiretroviral therapy (2003) (60)
Isolation of simian immunodeficiency viruses from two sooty mangabeys in Côte d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains. (1994) (59)
Most env and gag Subtype A HIV‐1 Viruses Circulating in West and West Central Africa Are Similar to the Prototype AG Recombinant Virus IBNG (2000) (59)
HIV-1 subtypes and recombinants in the Republic of Congo. (2006) (59)
High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo (2011) (59)
Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV (2020) (58)
HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso as assessed by an autologous heteroduplex mobility procedure (2004) (57)
Prevalence of HTLV‐I and HTLV‐II infection in gabon, africa: Comparison of the serological and pcr results (1991) (57)
Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon (2012) (57)
Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks (2021) (56)
A 84‐month follow up of adherence to HAART in a cohort of adult Senegalese patients (2007) (56)
Patterns of Resistance Mutations to Antiretroviral Drugs in Extensively Treated HIV‐1‐Infected Patients With Failure of Highly Active Antiretroviral Therapy (2001) (55)
Survey of Ebola Viruses in Frugivorous and Insectivorous Bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015–2017 (2018) (53)
HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC). (2006) (53)
Field Assessment of Generic Antiretroviral Drugs: A Prospective Cohort Study in Cameroon (2005) (53)
Seroepidemiological survey of HTLV-I infection among randomized populations of western central African countries. (1989) (53)
Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative. (2005) (53)
Antigenic evidence of the presence of the aberrant HIV‐1ANT70 virus in Cameroon and Gabon (1993) (53)
Gorilla gorilla gorilla gut: a potential reservoir of pathogenic bacteria as revealed using culturomics and molecular tools (2014) (53)
Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J. (2001) (53)
Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors (2012) (52)
Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon (2014) (52)
High level of hepatitis C endemicity in Gabon, equatorial Africa. (1993) (52)
Full-length sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two co-circulating SIVmus lineages. (2007) (51)
Partial Molecular Characterization of Two Simian Immunodeficiency Viruses (SIV) from African Colobids: SIVwrc from Western Red Colobus (Piliocolobus badius) and SIVolc from Olive Colobus (Procolobus verus) (2003) (51)
Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study. (2009) (51)
Widely varying SIV prevalence rates in naturally infected primate species from Cameroon. (2006) (51)
Quality of life and depression among HIV‐infected patients receiving efavirenz‐ or protease inhibitor‐based therapy in Senegal (2007) (51)
High genetic diversity of HIV-1 strains in Chad, West Central Africa. (2003) (51)
Phylogenetic analysis of a new chimpanzee lentivirus SIVcpz-gab2 from a wild-captured chimpanzee from Gabon. (1994) (50)
Seroprevalence of HIV-1, HIV-2, and HIV-1 group O in Nigeria: evidence for a growing increase of HIV infection. (1997) (49)
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. (2020) (49)
Identification and molecular characterization of new STLV-1 and STLV-3 strains in wild-caught nonhuman primates in Cameroon. (2008) (49)
Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays. (2010) (48)
Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment. (2019) (48)
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis. (2013) (48)
The identification of a complex A/G/I/J recombinant HIV type 1 virus in various West African countries. (1999) (48)
Intestinal Parasitic Infections in HIV-Infected Patients, Lao People’s Democratic Republic (2014) (48)
Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa. (2002) (47)
Identification and molecular characterization of subsubtype A4 in central Africa. (2006) (45)
Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon (2013) (45)
Revisiting Long-Term Adherence to Highly Active Antiretroviral Therapy in Senegal Using Latent Class Analysis (2011) (44)
Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test (2018) (44)
Risk of Virological Failure and Drug Resistance During First and Second-Line Antiretroviral Therapy in a 10-Year Cohort in Senegal: Results From the ANRS 1215 Cohort (2013) (44)
Adherence to Antiretroviral Treatment in HIV-Positive Patients in the Cameroon Context: Promoting the Use of Medication Reminder Methods (2011) (42)
High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo. (2011) (42)
Lamivudine-Resistant HBV Infection in HIV-Positive Patients Receiving Antiretroviral Therapy in a Public Routine Clinic in Cameroon (2012) (42)
Resistance to Antiretroviral Drugs in Treated and Drug-Naive Patients in the Democratic Republic of Congo (2011) (42)
Full-Length Genome Characterization of a Novel Simian Immunodeficiency Virus Lineage (SIVolc) from Olive Colobus (Procolobus verus) and New SIVwrcPbb Strains from Western Red Colobus (Piliocolobus badius badius) from the Taï Forest in Ivory Coast (2008) (42)
Prevalence of gastrointestinal parasites in primate bushmeat and pets in Cameroon. (2011) (42)
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon. (2008) (42)
Comparison of Drug Resistance Mutations and Their Interpretation in Patients Infected With Non-B HIV-1 Variants and Matched Patients Infected With HIV-1 Subtype B (2004) (42)
Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus (2016) (41)
High prevalence of anti-hepatitis C virus antibodies in a Cameroon rural forest area. (1994) (41)
Evaluation of Four Simple/Rapid Assays and Two Fourth-Generation FLISAs for the Identification of HIV Infection on a Serum Panel Representing the HIV-1 Group M Genetic Diversity in Cameroon (2004) (41)
Ocular Complications in Survivors of the Ebola Outbreak in Guinea. (2017) (41)
Molecular Evidence for the Presence of Rickettsia Felis in the Feces of Wild-living African Apes (2013) (41)
Detection of Termites and Other Insects Consumed by African Great Apes using Molecular Fecal Analysis (2014) (41)
Identification of a complex env subtype E HIV type 1 virus from the democratic republic of congo, recombinant with A, G, H, J, K, and unknown subtypes. (2000) (40)
CRF06‐cpx: A New Circulating Recombinant Form of HIV‐1 in West Africa Involving Subtypes A, G, K, and J (2002) (40)
Evidence of stable HIV seroprevalences in selected populations in the Democratic Republic of the Congo (1998) (40)
Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine (2007) (39)
HTLV-II among pygmies from Cameroon. (1993) (39)
Manifestations cutanées observées au cours d’un traitement par anti-TNF alpha : 11 observations (2007) (39)
Predominance of CRF02-AG and CRF06-cpx in Niger, West Africa. (2002) (39)
Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon (2010) (39)
Political and socioeconomic instability: how does it affect HIV? A case study in the Democratic Republic of Congo. (2004) (39)
CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. (2002) (38)
Rapid Confirmation of the Zaire Ebola Virus in the Outbreak of the Equateur Province in the Democratic Republic of Congo: Implications for Public Health Interventions (2018) (38)
High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity (2011) (38)
Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon (2015) (38)
Antiretroviral Drug Resistance and Routine Therapy, Cameroon (2006) (37)
Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy. (2001) (37)
Interpatient genetic variability of HIV-1 group O. (1999) (37)
Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa (2015) (37)
Simian retroviruses in African apes. (2012) (36)
Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 and HIV-2 infected women in Dakar, Senegal (2001) (36)
Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215). (2010) (35)
Further evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon. (1994) (35)
Emergence of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV type 1 strains in Niger, West Africa. (2003) (35)
High rates of active hepatitis B and C co‐infections in HIV‐1 infected Cameroonian adults initiating antiretroviral therapy (2010) (34)
Co-circulation of enteroviruses between apes and humans. (2014) (33)
TRAITEMENT DU LUPUS ERYTHEMATEUX CHRONIQUE PAR LA SULFASALAZINE : 11 OBSERVATIONS (1994) (33)
HIV type 1 diversity and antiretroviral drug resistance mutations in Burundi. (2007) (32)
Adherence to Antiretroviral Therapy Assessed by Drug Level Monitoring and Self-Report in Cameroon (2008) (31)
Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U. (2009) (31)
Seroprevalence of retroviral infection in women with different fertility statuses in Gabon, western equatorial Africa. (1991) (31)
Demographic factors associated with HTLV-1 infection in a Gabonese community. (1994) (30)
Long-lasting severe immune dysfunction in Ebola virus disease survivors (2019) (30)
Novel Multiplexed HIV/Simian Immunodeficiency Virus Antibody Detection Assay (2011) (30)
Task Shifting HIV Care in Rural District Hospitals in Cameroon: Evidence of Comparable Antiretroviral Treatment-Related Outcomes Between Nurses and Physicians in the Stratall ANRS/ESTHER Trial (2013) (30)
Prevalence and genetic diversity of simian immunodeficiency virus infection in wild-living red colobus monkeys (Piliocolobus badius badius) from the Taï forest, Côte d'Ivoire SIVwrc in wild-living western red colobus monkeys. (2008) (29)
Genetic characterization of the nef gene from human immunodeficiency virus type 1 group M strains representing genetic subtypes A, B, C, E, F, G, and H. (1999) (29)
Investigation of minor species Candida africana, Candida stellatoidea and Candida dubliniensis in the Candida albicans complex among Yaoundé (Cameroon) HIV‐infected patients (2015) (28)
Noninvasive Follow-Up of Simian Immunodeficiency Virus Infection in Wild-Living Nonhabituated Western Lowland Gorillas in Cameroon (2012) (28)
Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study. (2019) (28)
Reduced Quantitative Ultrasound Bone Mineral Density in HIV-Infected Patients on Antiretroviral Therapy in Senegal (2012) (27)
Phylogenetic analysis of Brazilian HIV type 1 subtype D strains: tracing the origin of this subtype in Brazil. (2006) (27)
Successful integrase inhibitor-based highly active antiretroviral therapy for a multidrug-class-resistant HIV type 1 group O-infected patient in Cameroon. (2013) (26)
Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2). (2004) (26)
2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation. (2019) (26)
Ubiquitous Hepatocystis infections, but no evidence of Plasmodium falciparum-like malaria parasites in wild greater spot-nosed monkeys (Cercopithecus nictitans). (2012) (26)
Humoral responses against the 85A and 85B antigens of Mycobacterium bovis BCG in patients with leprosy and tuberculosis (1992) (26)
Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis. (2013) (26)
Absence of a relationship between antibodies to hepatitis C virus and hepatocellular carcinoma in Mozambique. (1993) (26)
Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings (2008) (25)
Age-related prevalence of antibody response against three different, defined Plasmodium falciparum antigens in children from the Haut-Ogooué province in Gabon. (1989) (25)
HIV and Hepatitis C Virus Coinfection, Cameroon (2007) (25)
Identification and molecular characterization of new simian T cell lymphotropic viruses in nonhuman primates bushmeat from the Democratic Republic of Congo. (2012) (25)
Full molecular characterization of a simian immunodeficiency virus, SIVwrcpbt from Temminck's red colobus (Piliocolobus badius temminckii) from Abuko Nature Reserve, The Gambia. (2008) (25)
Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole. (2015) (25)
Evidence for a Second Simian T-Cell Lymphotropic Virus Type 3 inCercopithecus nictitans from Cameroon (2001) (25)
Assessment of gastrointestinal parasites in wild chimpanzees (Pan troglodytes troglodytes) in southeast Cameroon (2014) (24)
Granulome annulaire après vaccination par le BCG (2001) (24)
Wild gorillas as a potential reservoir of Leishmania major. (2015) (24)
CRF06-cpx is the predominant HIV-1 variant in AIDS patients from Ouagadougou, the capital city of Burkina Faso. (2003) (24)
Long-term efficacy and tolerance of efavirenz- and nevirapine-containing regimens in adult HIV type 1 Senegalese patients. (2008) (24)
Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China (2012) (24)
Enfuvirtide binding domain is highly conserved in non-B HIV type 1 strains from Cameroon, West Central Africa. (2005) (24)
High Rates of Drug Resistance Among Newly Diagnosed HIV-infected Children in the National Prevention of Mother-to-child Transmission Program in Togo (2016) (24)
Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea (2017) (24)
Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients. (2013) (24)
High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey. (2021) (24)
HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges. (2015) (24)
Time Patterns of Adherence and Long-Term Virological Response to Non-Nucleoside Reverse Transcriptase Inhibitor Regimens in the Stratall Anrs 12110/Esther Trial in Cameroon (2013) (24)
Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV‐1ANT‐70 isolate in human sera from different geographic regions (1994) (23)
Human T-cell leukemia virus type I isolates from Gabon and Ghana: comparative analysis of proviral genomes. (1987) (23)
Molecular tracing of sexual HIV Type 1 transmission in the southwest border of China. (2008) (23)
V3 serotyping of HIV-1 infection: correlation with genotyping and limitations. (1999) (23)
HTLV-I infection among prostitutes and pregnant women in Kinshasa, Zaïre: how important is high-risk sexual behavior? (1995) (23)
Genetic characterization of accessory genes from human immunodeficiency virus type 1 group O strains. (1998) (23)
Prospective evaluation of a flow chart using a risk assessment for the diagnosis of STDs in primary healthcare centres in Libreville, Gabon. (1998) (23)
Evidence of HTLV-II infection in central Africa. (1991) (23)
HTLV-I INFECTION IN WESTERN EQUATORIAL AFRICA (1989) (22)
Prevalence and transmission of simian immunodeficiency virus and simian T-cell leukemia virus in a semi-free-range breeding colony of mandrills in Gabon. (1991) (22)
Presence of HIV-1 group O infection in West Africa. (1996) (22)
Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort (2010) (22)
Commercial Logging and HIV Epidemic, Rural Equatorial Africa (2004) (22)
A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of Ebola Viral Ribonucleic Acid in Semen and Breast Milk (2019) (21)
In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa (2016) (21)
Molecular epidemiological tracing of HIV-1 outbreaks in Hainan island of southern China (2009) (21)
Prevalence of the human immunodeficiency virus among patients with tuberculosis in Sierra Leone, established from dried blood spots on filter paper. (1997) (21)
Evidence for HIV-1 group O infection in Nigeria (1995) (21)
Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting (2019) (21)
Genetic and antigenic variability of HIV type 1 in Brazil. (1994) (20)
Implementation and Operational Research: Programmatic Feasibility of Dried Blood Spots for the Virological Follow-up of Patients on Antiretroviral Treatment in Nord Kivu, Democratic Republic of the Congo (2015) (20)
Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor–Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis (2020) (20)
Evaluation of Two Techniques for Viral Load Monitoring Using Dried Blood Spot in Routine Practice in Vietnam (French National Agency for AIDS and Hepatitis Research 12338) (2016) (20)
Molecular characterization of a novel simian immunodeficiency virus lineage (SIVtal) from northern talapoins (Miopithecus ogouensis). (2006) (20)
Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries. (1998) (20)
Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV‐positive patients (2016) (19)
Pemphigoïde du sujet jeune: Étude rétrospective de 74 cas (2005) (19)
Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo (2015) (19)
Treatment Regimens of STD Patients in Cameroon: A Need for Intervention (1994) (19)
Clinical algorithms for the screening of pregnant women for STDs in Libreville, Gabon: which alternatives? (1998) (19)
Nonhuman primate retroviruses from Cambodia: high simian foamy virus prevalence, identification of divergent STLV-1 strains and no evidence of SIV infection. (2013) (19)
Pathogenic Eukaryotes in Gut Microbiota of Western Lowland Gorillas as Revealed by Molecular Survey (2014) (19)
Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Côte d'Ivoire, West Africa. (2005) (18)
Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon (2010) (18)
Evaluation de l'impact bioclinique et social, individuel et collectif, du traitement ARV chez des patients VIH-1 pris en charge depuis 10 ans dans le cadre de l'ISAARV - Cohorte ANRS 1215. Rapport final (2012) (18)
Prevalence and risk assessment for sexually transmitted infections in pregnant women and female sex workers in Mali: is syndromic approach suitable for screening? (1999) (18)
Change over time of mortality predictors after HAART initiation in a Senegalese cohort (2008) (17)
Wide Diversity of Coronaviruses in Frugivorous and Insectivorous Bat Species: A Pilot Study in Guinea, West Africa (2020) (17)
Hepatitis C in remote populations of southern Cameroon. (1994) (17)
Effect of HIV-1 genetic diversity on HIV-1 RNA quantification in plasma: comparative evaluation of three commercial assays. (1997) (17)
Manifestations dermatologiques des maladies inflammatoires du tube digestif (1992) (17)
Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study. (2020) (17)
Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa. (2016) (17)
Tenofovir-Emtricitabine-Efavirenz in HIV-I-Infected Adults in Senegal: A 96-Week Pilot Trial in Treatment-Naive Patients (2009) (16)
Prevalence and genetic variants of hepatitis GB-C/HG and TT viruses in Gabon, equatorial Africa. (2000) (16)
Non‐hodgkin lymphoma in gabon and its relation to HTLV‐I (1993) (16)
Full-length genome sequence of a simian immunodeficiency virus (SIV) infecting a captive agile mangabey (Cercocebus agilis) is closely related to SIVrcm infecting wild red-capped mangabeys (Cercocebus torquatus) in Cameroon (2010) (16)
Congenital hydrocephalus due to intrauterine HTLV-I infection (1991) (16)
Low rate of hepatitis C virus antibodies in blood donors and pregnant women from Niger. (1992) (16)
Phylogénie des SIV et des VIH - Mieux comprendre l’origine des VIH (2008) (16)
Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France. (2008) (16)
Extensive serological survey of multiple African non-human primate species reveals low prevalence of IgG antibodies to four Ebola virus species. (2019) (16)
Comparison of different nucleic acid preparation methods to improve specific HIV-1 RNA isolation for viral load testing on dried blood spots. (2018) (16)
Full-length genome sequencing of HIV type 1 group O viruses isolated from a heterosexual transmission cluster in Senegal. (2001) (16)
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study (2019) (16)
Population-based study of serum hepatitis B virus DNA in Gabon. (1993) (15)
Development and Evaluation of a DNA Enzyme Immunoassay Method for env Genotyping of Subtypes A through G of Human Immunodeficiency Virus Type 1 Group M, with Discrimination of the Circulating Recombinant Forms CRF01_AE and CRF02_AG (2002) (15)
Complications cutanées de la radiothérapie (hors tumeurs malignes) (2003) (15)
Evaluation of Four Tenofovir-Containing Regimens as First-Line Treatments in Cameroon and Senegal: The Anrs 12115 Dayana Trial (2014) (15)
The fourth HIV epidemic. (2018) (15)
Integration of genomic sequencing into the response to the Ebola virus outbreak in Nord Kivu, Democratic Republic of the Congo (2021) (15)
High Rates of Infection with Novel Enterovirus Variants in Wild Populations of Mandrills and Other Old World Monkey Species (2014) (15)
Activité de consultation de trois services de dermatologie hospitalo-universitaires français (2006) (14)
Use of RNAlater as a preservation method for parasitic coprology studies in wild-living chimpanzees. (2013) (14)
Advances in clinical trial design: Weaving tomorrow’s TB treatments (2020) (14)
Virological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis (2017) (14)
Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon (2022) (14)
Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings. (2008) (13)
Role of Wildlife in Emergence of Ebola Virus in Kaigbono (Likati), Democratic Republic of the Congo, 2017 (2020) (13)
Call for action to secure universal access to ART in developing countries (2010) (13)
Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast (2018) (13)
Subtype-specific polymerase chain reaction for the identification of HIV-1 genetic subtypes circulating in Africa. (1998) (13)
High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey (2021) (13)
Multiplex detection of antibodies to Chikungunya, O'nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo. (2021) (13)
Complete nucleotide sequence of an African human T-lymphotropic virus type II subtype b isolate (HTLV-II-Gab): molecular and phylogenetic analysis. (1998) (12)
Interpretation of antibodies reacting solely with human retroviral core proteins in western equatorial Africa. (1989) (12)
First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam (2018) (12)
Characteristics of the musculoskeletal symptoms observed among survivors of Ebola virus disease in the Postebogui cohort in Guinea (2017) (12)
[Prevalence of the HIV infection and five other sexually-transmitted infections among sex workers in Niamey, Niger]. (2006) (12)
High frequency of HIV-1 infections with multiple HIV-1 strains in men having sex with men (MSM) in Senegal. (2013) (12)
Extraordinary long-term and fluctuating persistence of Ebola virus RNA in semen of survivors in Guinea: implications for public health. (2017) (12)
Non-contiguous finished genome sequence and description of Gorillibacterium massiliense gen. nov, sp. nov., a new member of the family Paenibacillaceae (2014) (12)
Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets (2016) (12)
Divergent HIV-1 strains (CRF92_C2U and CRF93_cpx) co-circulating in the Democratic Republic of the Congo: Phylogenetic insights on the early evolutionary history of subtype C (2017) (12)
Blood transfusion as a major risk factor for HTLV-I infection among hospitalized children in Gabon (Equatorial Africa). (1993) (11)
Long‐term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral‐naive patients: a 9‐year cohort study in Senegal (2011) (11)
HIV type-1 group O infection in Gabon: low prevalence rate but circulation of genetically diverse and drug-resistant HIV type-1 group O strains. (2013) (11)
New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon (2015) (11)
Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy. (2015) (11)
CRF45_AKU, a circulating recombinant from Central Africa, is probably the common ancestor of HIV type 1 MAL and HIV type 1 NOGIL. (2009) (11)
Toxidermie lichénoïde au léflunomide (Arava). (2003) (11)
Epidemiology of HIV1 infection among randomized representative Central African populations (1987) (11)
Characterization of HIV-1 genotypes and antiretroviral drug-resistance mutations among patients in Burkina Faso. (2011) (11)
WHO clinical criteria–based initiation of antiretroviral therapy: lessons from rural district hospitals in Cameroon with regard to 2009 revised WHO recommendations (2010) (10)
Seroepidemiological survey of HIV-1 and HIV-2 antibodies in Gabon. (1988) (10)
Differentiation between HIV-1 and HIV-2 infection by radioimmunoprecipitation and synthetic peptides in double reactive sera. (1989) (10)
Full-Length Genome Analyses of Two New Simian Immunodeficiency Virus (SIV) Strains from Mustached Monkeys (C. Cephus) in Gabon Illustrate a Complex Evolutionary History among the SIVmus/mon/gsn Lineage (2014) (10)
First case of mixed infection with Cryptococcus deuterogattii and Cryptococcus neoformans VNI in an Ivorian HIV-positive patient (2016) (10)
[Genetic diversity and phylogeographic distribution of SIV: how to understand the origin of HIV]. (2008) (10)
High prevalence of CRF02_AG and many minor resistance-related mutations at the protease gene among HIV-infected treatment-naive immigrants in Madrid. (2003) (10)
Folliculite disséquante du cuir chevelu: efficacité de l'isotrétinoïne. (1994) (10)
A novel multiregion hybridization assay reveals high frequency of dual inter-subtype infections among HIV-positive individuals in Cameroon, West Central Africa. (2013) (9)
Changes in sexual activity and risk behaviors among PLWHA initiating ART in rural district hospitals in Cameroon – Data from the STRATALL ANRS 12110/ESTHER trial (2013) (9)
Urticaire solaire : désensibilisation UVA avant PUVAthérapie (2000) (9)
Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon. (2013) (9)
Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM) (2018) (9)
Dual therapy with a boosted protease inhibitor plus lamivudine is an effective maintenance strategy in patients on second-line antiretroviral therapy in Africa : the ANRS 12286/MOBIDIP trial (2016) (9)
[The prevalence of anti-hepatitis C antibodies in pregnant women and blood donors in Bénin]. (1995) (9)
Cryptococcus neoformans isolates from Yaoundé human immunodeficiency virus-infected patients exhibited intra-individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient. (2016) (9)
Antiretroviral drug resistance in HIV-1 infected patients receiving antiretroviral treatment in routine clinics in Cotonou, Benin (2011) (9)
Failure to Detect Simian Immunodeficiency Virus Infection in a Large Cameroonian Cohort with High Non-human Primate Exposure (2012) (9)
DIAGNOSTIC APPROACHES TO IMPORTED SCHISTOSOMAL MYELORADICULOPATHY IN TRAVELERS (2008) (9)
Erratum to: High Prevalences and a Wide Genetic Diversity of Simian Retroviruses in Non-human Primate Bushmeat in Rural Areas of the Democratic Republic of Congo (2017) (8)
L’hibernome : une tumeur adipocytaire rare et méconnue (2011) (8)
Les dermatoses professionnelles des coiffeurs (1993) (8)
Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo (2015) (8)
Weight gain stopping/switch rules for antiretroviral clinical trials. (2021) (8)
Impact of HIV Comprehensive Care and Treatment on Serostatus Disclosure among Cameroonian Patients in Rural District Hospitals (2013) (8)
Susceptibility to Transmitting HIV in Patients Initiating Antiretroviral Therapy in Rural District Hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial) (2013) (8)
Susceptibility to Transmitting HIV in Patients Initiating Antiretroviral Therapy in Rural District Hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial) (2013) (8)
Genetic diversity of STLV-2 and interspecies transmission of STLV-3 in wild-living bonobos (2016) (8)
[Epidemiological features of retroviral infection by HTLV-1 in central Africa]. (1993) (8)
Adherence as a Predictor of Sexual Behaviors in People Living with HIV/AIDS during the First Year of Antiretroviral Therapy in Rural Cameroon: Data from Stratall ANRS 12110/ESTHER Trial (2012) (8)
High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV) (2022) (8)
Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015 (2020) (7)
Place of antiretroviral drugs in the treatment of HIV-infected people in Africa. International AIDS Society. (1999) (7)
Retrovirus infections in the south of Cameroon. (1992) (7)
Rapid spread of HIV infections in Abidjan, Ivory Coast, 1987–1990 (1992) (7)
Lack of Evidence of Simian Immunodeficiency Virus Infection Among Nonhuman Primates in Taï National Park, Côte d’Ivoire: Limitations of Noninvasive Methods and SIV Diagnostic Tools for Studies of Primate Retroviruses (2011) (7)
[HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study]. (2002) (7)
Actualisation des recommandations françaises de traitement du pemphigus (2019) (7)
Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa. (2014) (7)
Universal health coverage and HIV in resource-constrained countries: a critical juncture for research and action. (2013) (7)
Hepatitis C virus antibodies in prostitutes in Niger. (1994) (7)
Detection of HIV-2 antibodies using five commercial HIV enzyme immunoassays. (1988) (7)
Understanding the long-term evolution and predictors of sequelae of Ebola virus disease survivors in Guinea: A 48-month prospective, longitudinal cohort study (PostEboGui). (2021) (7)
Understanding the long-term evolution and predictors of sequelae of Ebola virus disease survivors in Guinea: A 48-month prospective, longitudinal cohort study (PostEboGui). (2021) (7)
Maladie de Launois-Bensaude : à propos de 17 cas (2008) (7)
Prevalence of hepatitis B antigen among randomized representative urban and rural populations in Gabon. (1988) (7)
Affections inflammatoires à médiation immunitaire et psoriasis (2008) (6)
Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal (2007) (6)
Molecular characterization of a new mosaic Simian Immunodeficiency Virus in a naturally infected tantalus monkey (Chlorocebus tantalus) from Cameroon: a challenge to the virus-host co-evolution of SIVagm in African green monkeys. (2015) (6)
[Genetic diversity of HIV infection worldwide and its consequences]. (1999) (6)
Genetic diversity of simian lentivirus in wild De Brazza’s monkeys (Cercopithecus neglectus) in Equatorial Africa (2010) (6)
Pyoderma gangrenosum avec localisations pulmonaires traité par infliximab (2013) (6)
[Hibernoma: an uncommon adipocytic tumor]. (2011) (6)
Multimorbidity in Elderly Subjects according to the year of diagnosis of HIV-Infection - A Cross-Sectional DATAIDS Cohort Study. (2019) (6)
Origin and Emergence of HIV/AIDS (2011) (6)
Rhabdomyosarcome sur site d'implantation d'un stimulateur cardiaque (2000) (6)
Genetic diversity of the Hwp1 gene and HIS3, EF3, CDC3 microsatellites and antifungal susceptibility profiles of Candida albicans isolates from Yaoundé HIV‐infected patients (2016) (6)
Operational research and HIV policy and guidelines: Lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon (2012) (6)
Nécroses cutanées induites par le léflunomide (2008) (6)
Genetic diversity and transmission networks of HIV-1 strains among men having sex with men (MSM) in Lomé, Togo. (2016) (6)
Microelimination or not? The changing epidemiology of HIV-HCV coinfection in France 2012-2018. (2021) (6)
Analyse des signes cliniques des malades atteints de pemphigoïde en fonction des antigènes reconnus par leur sérum en immunotransfert (2004) (6)
Epidémiologie du virus de l'hépatite C (1995) (6)
Investigating the Circulation of Ebola Viruses in Bats during the Ebola Virus Disease Outbreaks in the Equateur and North Kivu Provinces of the Democratic Republic of Congo from 2018 (2021) (6)
[Mycosis fungoides in a Gabonese patient infected with HTLV-I]. (1996) (6)
Bilan étiologique et traitement d’une urticaire chronique (2003) (6)
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial) (2020) (5)
Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study. (2021) (5)
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings (2012) (5)
Sarcoïdose familiale: trois cas dans la même fratrie (1995) (5)
[Seroprevalence of syphilis in urban and semi-rural populations of Gabon]. (1988) (5)
Interactions kératinocytes-fibroblastes. I: Production par les kératinocytes de facteurs solubles stimulant la prolifération de fibroblastes dermiques humains normaux (1989) (5)
Non-contiguous-Finished Genome Sequence and Description of Paenibacillus camerounensis sp. nov. (2016) (5)
ART initiation in an outpatient treatment center in Dakar, Senegal: A retrospective cohort analysis (1998-2015) (2018) (5)
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial) (2020) (5)
Dysplasies hamartomateuses avec hémihypertrophie: deux observations dont un syndrome Protée (1995) (5)
Traitement du lupus érythémateux chronique par sulfasalazine (18 cas) (2006) (5)
HIV/AIDS Infection in the World With a Special Focus on Africa (2006) (5)
Efficacité et tolérance du traitement antirétroviral dans le contexte de l'Initiative sénégaliase d'accès aux antirétroviraux (2002) (4)
À propos d'une association VIH et noma au Niger (2002) (4)
Rougeole: Diagnostic et prise en charge d'une maladie toujours d'actualité* (2008) (4)
Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal. (2007) (4)
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM) (2020) (4)
The Public Health Approach to Antitretroviral Treatment: The Case of Cameroon (2008) (4)
Peau et affections du tube digestif (2007) (4)
Endocardite à Bacillus cereus avec probable porte d’entrée cutanée. (2017) (4)
Manifestations révélatrices et retard diagnostique dans la polychondrite chronique atrophiante: à propos d'une série de 15 malades (1996) (4)
Assessment of Infections with Microsporidia and Cryptosporidium spp. in Fecal Samples from Wild Primate Populations from Cameroon and Democratic Republic of Congo (2015) (4)
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM) (2020) (4)
HIV Infection Does Not Explain Elevation of Glycated Hemoglobin among Non-Diabetic Patients in Gabon (2000) (4)
Human T-cell lymphotropic virus type I infection and pregnancy: A case-control study and 12-month follow-up of 135 women and their infants (1991) (4)
Psoriasis et maladies inflammatoires du tube digestif (2012) (4)
The Use of a Line Probe Assay as a Tool to Detect New Types or Subtypes of the Hepatitis C Virus (1994) (4)
Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa (2019) (4)
Septic shock secondary to an acute necrotizing community-acquired pneumonia with bacteremia due to Pseudomonas aeruginosa (2019) (4)
A 40 months follow-up of Ebola virus disease survivors in Guinea (Postebogui) reveals longterm detection of Ebola viral RNA in semen and breast milk. (2019) (4)
Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa (2019) (4)
[Revival after Ebola: multidisciplinary assessment at 1 year, prospect and follow-up study of surviving patients from Ebola in Guinea (PostEboGui cohort)]. (2016) (4)
Evidence of STLV 2 and STLV 3 infections in wild living bonobos (P. paniscus ) from the Democratic Republic of Congo (2011) (4)
Short Communication: Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir. (2018) (3)
Operationalizing genomic epidemiology during the Nord-Kivu Ebola outbreak, Democratic Republic of the Congo. (2020) (3)
Avons-nous vraiment besoin de la « dermatose éosinophilique des hémopathies » ? (2010) (3)
Corticothérapie locale brève + méthotrexate vs corticothérapie locale seule prolongée dans la pemphigoïde bulleuse : essai national multicentrique (2017) (3)
Evidence of STLV-2 and STLV-3 infections in wild-living bonobos (P. paniscus ) from the Democratic Republic of Congo (2011) (3)
C19 - Lymphomes pilotropes avec ou sans mucine : un profil évolutif distinct ? Étude multicentrique du groupe français d’étude des lymphomes cutanés (2005) (3)
Carcinomes basocellulaires multiples après traitement d'un psoriasis par étanercept (2009) (3)
Antiretroviral drugs in Africa: a public health versus a market approach. (2013) (3)
Absence de lien entre infection par le virus de l'hépatite C et diabète au Gabon. (2000) (3)
Human T‐cell lymphotropic virus type I infection and pregnancy: A case‐control study and 12‐month follow‐up of 135 women and their infants (1992) (3)
Hepatitis B and delta infection in Gabon: a seriological survey in a representative sample of the province of Haut-Ogooue. (1989) (3)
HTLV-I infection in Western Equatorial Africa [letter] (1989) (3)
Origin of HIV/AIDS and risk for ongoing zoonotic transmissions from nonhuman primates to humans (2010) (3)
REACTIVITIES OF ANTIBODIES TO HIV AND SIV IN HUMAN SERA IN KENYA, GABON, AND GHANA (1988) (3)
Allergie à l’insuline humaine recombinante : à propos de 3 cas avec manifestations immédiates généralisées (2003) (3)
African ST173 Cryptococcus deuterogattii strains are commonly less susceptible to fluconazole: an unclear mechanism of resistance. (2019) (3)
Evolution of Renal Function in African Patients Initiating Second-Line Antiretroviral Treatment: Findings from the ANRS 12169 2LADY Trial (2016) (3)
Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon. (2016) (3)
Contribution des fratries non vaccines une flambe de rougeole en Suisse (2004) (3)
Élaboration et évaluation d’algorithmes de dépistage des MST chez la femme enceinte à Libreville, Gabon (1996) (3)
Séroprévalence du virus de l'hépatite C parmi les personnes fréquentant les services de soins du Burundi. (1995) (3)
Dermatoses dues aux antiseptiques, aux aldéhydes, aux détergents (1993) (3)
Getting pregnant in HIV clinical trials: women’s choice and safety needs. The experience from the ANRS12169-2LADY and ANRS12286-MOBIDIP trials (2016) (3)
[A case of tropical spastic paraparesis associated with HTLV1 in the Niger Republic]. (1996) (3)
Peau et éosinophilie (2007) (3)
Impact à long terme des traitements antirétroviraux en Afrique, état des connaissances (2014) (3)
Nécrolyse épidermique toxique à la lamotrigine par erreur de délivrance (2010) (3)
Non-contiguous finished genome sequence and description of Paenibacillus gorillae sp. nov. (2014) (3)
La diversité génétique du VIH1 (2000) (3)
L'occlusion: une complication rare du nævus bleu géant congénital en culotte (1995) (3)
Les outils thérapeutiques de l’angiome plan (2013) (3)
Individual and healthcare supply-related barriers to treatment initiation in HIV-positive patients enrolled in the Cameroonian antiretroviral treatment access programme. (2020) (2)
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
Serological Evidence of Ebola Virus Infection in Rural Guinea before the 2014 West African Epidemic Outbreak. (2018) (2)
Frequency of antiretroviral resistance mutations among ART-naive HIV-1-infected populations in rural areas from Cameroon (2010) (2)
Efficacy of dual therapy with protease inhibitors plus lamivudine as maintenance treatment in HIV-positive patients on second line in Africa : the ANRS 12286/MOBIDIP trial 96-week results (2017) (2)
First report of cryptococcosis due to Cryptococcus gattii sensu stricto VGI in an Ivorian HIV negative patient. (2021) (2)
[Epidemiologic aspects of malaria in Gabon]. (1990) (2)
[Lack of association between hepatitis C virus infection and diabetes mellitus in Gabon]. (2000) (2)
Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon : week 96 results of the ANRS 12313-NAMSAL trial (2020) (2)
26 – Origin and Emergence of HIV/AIDS (2011) (2)
The genetic diversity of HIV1 (2000) (2)
Non-contiguous-Finished Genome Sequence and Description of Paenibacillus camerounensis sp. nov. (2015) (2)
Activité de consultation des services de dermatologie (2004) (2)
Challenges of scale-up to Dolutegravir based regimens in sub-Saharan Africa: a case study in Togo. (2019) (2)
Rapid spread of HIV infection in Côte d'Ivoire (1992) (2)
Candidose cutanée chronique à Candida krusei. (1992) (2)
Epidemiologie de l'infection HIV-2 en Afrique (1988) (2)
Maladie de Behçet : aspect comparatif des critères diagnostiques (1994) (2)
Leucémie lymphoïde chronique révélée par des infiltrats cutanés spécifiques en l’absence d’hyperlymphocytose : deux observations (2012) (2)
A simple clinical and paraclinical score predictive of CD4 cells counts below 400/mm3 in HIV-infected adults in Dakar University Hospital, Senegal. (2002) (2)
[Long-term impact of antiretroviral therapy in Africa: current knowledge]. (2014) (2)
A case series of 11 uveitis in patients who recovered from Ebola in Guinea (2015) (2)
New technologies for controlling emerging infectious diseases in Guinea and the Democratic Republic of the Congo: their role in response to the Ebola epidemic. (2019) (2)
Diversité génétique de l'infection à VIH dans le monde et ses conséquences (1999) (2)
Malintrop Afrique : manuel de maladies infectieuses pour l'Afrique (2002) (2)
Hépatite C: épidémiologie et importance en santé publique (1995) (2)
Seroprevalence of IgG Antibodies Against Multiple Arboviruses in Bats from Cameroon, Guinea, and the Democratic Republic of Congo. (2022) (2)
Track E Implementation Science, Health Systems and Economics (2012) (1)
Emergence of high-level tetracycline resistant Neisseria gonorrhoeae in high risk population in Dakar (Senegal). (1998) (1)
Infections à Mycobacterium simiae : à propos de deux cas (2005) (1)
Séquelles neurologiques de l’infection à virus Ebola (2017) (1)
High viral load in patients failing first line ART is associated with multidrug resistance in resource limited countries (2014) (1)
Nonlinear multiple imputation for continuous covariate within semiparametric Cox model: application to HIV data in Senegal (2013) (1)
Une mauvaise prise de greffe (2002) (1)
[Status of HIV infection in Libreville Gabon: evolution from 1986 to 1991] (1992) (1)
Prévention par la corticothérapie des toxidermies au triméthoprime-sulfaméthoxazole chez les sidéens traités pour pneumocystose pulmonaire (1994) (1)
Réaction paradoxale au rituximab prescrit pour une vascularite cryoglobulinémique (2021) (1)
No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study. (2021) (1)
Cas pour diagnostic: lymphangite sclérosante de la verge. (1994) (1)
[HIV infection in Libreville, Gabon. Developments from 1986 to 1991]. (1992) (1)
Population-based sero-epidemiological investigation of the dynamics of SARS-CoV-2 infections in the Greater Accra Region of Ghana (2022) (1)
Évaluation d’un programme d’éducation thérapeutique du patient atteint de psoriasis dans le service de dermatologie du CHRU de Lille (2016) (1)
Role of sexually transmissible pathogens in transmitting HIV I. (1988) (1)
Prevalence and genetic diversity of simian immunodeficiency virus infection in wold red colobus monkeys (Piliocolobus badius badius) from the Tai Forest, Cote d'Ivoire (2008) (1)
Multiply spliced env and nef transcripts of simian immunodeficiency virus from West African green monkey (SIVagm-sab). (1998) (1)
Correction: Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China (2013) (1)
[Epidemiology of HTLV-I infection in its hyperendemic foci (Japan, tropical Africa, Caribbean)]. (1990) (1)
Dermolipectomie abdominale et mastectomie bilatérale subtotale dans le cadre d’une calciphylaxie : à propos d’un cas et mise au point (2015) (1)
Correction: Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China (2013) (1)
Incidence of Infectious Morbidity Events after Second-Line Antiretroviral Therapy Initiation in HIV-Infected Adults in Yaoundé, Cameroon (2016) (1)
Ocular inflammatory diseases in ebola survivors (2017) (1)
Nodule du visage (2002) (1)
Aspects epidemiologiques du paludisme au Gabon (1990) (1)
Concepts raisonnés de la comptabilité économique (1)
Évaluation de l’expérience des médecins généralistes du département du Nord dans la prise en charge des réactions cutanées médicamenteuses (2011) (1)
(Re)vivre après Ebola : bilan à un an et perspectives d’une étude d’évaluation et accompagnement des patients déclarés guéris d’une infection par le virus Ebola en Guinée (cohorte PostEboGui) (2016) (1)
Seroprevalence of hepatitis C virus in outpatients of health care services in Burundi (1995) (1)
Avantages et inconvénients d'un nouveau type de cellules dendritiques dans la prise en charge du mélanome (2004) (1)
Heterogeneity of contact patterns with Ebola virus disease cases. (2021) (1)
Prevalence of Osteoporosis among HIV-1-Infected Men and Women Aged 50 years and Older in Dakar, Senegal: A Cross-Sectional Study (2015) (1)
TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study (2017) (1)
Éruption nodulo-kystique induite par le sorafénib (2019) (1)
DRESS syndrome à la sulfasalazine : intérêt du génotypage NAT2 (2013) (1)
[Development and evaluation of screening algorithms for sexually transmitted diseases in pregnant women at Libreville, Gabon]. (1996) (1)
Virological outcome and frequency of drug resistance mutations in HIV-infected patients receiving first-line ARV regimen and monitored with the clinical approach in the Cameroon National ART Program (2011) (1)
[Prevalence of hepatitis B and C virus, HTLV-1 and HIV in type B lymphoproliferative syndromes in Gabon]. (2003) (1)
Epidemiology of HTLV-I in Africa (1991) (1)
Corrélation entre les scores de sévérité clinique (ABSIS, PDAI, PGA), la qualité de vie (DLQI) et les taux d’Ac anti-desmogléine 1 et 3 dans le suivi du pemphigus (2015) (1)
Efficacité et tolérance des anti-TNF alpha dans le psoriasis pustuleux généralisé (2012) (1)
Using human immunode ciency virus type 1 sequences to infer historical features of the acquired immune de ciency syndrome epidemic and human immunode ciency virus evolution (2004) (1)
L'émergence des nouvelles épidémies s'accélère, comment y faire face ? (2020) (1)
[Acquired immunodeficiency syndrome (AIDS) in Gabon. Apropos of 23 cases at the internal medicine service of the hospital centers in Libreville and Franceville, 1985-1987]. (1988) (1)
Iconography : HBs Ag and antibodies to hepatitis C virus in complicated chronic hepatic diseases in Gabon (2008) (1)
Incidence et mortalité du pemphigus en France (2016) (1)
Syndrome de Stevens-Johnson lamifostine en cours de radiothrapie (2008) (1)
Des léiomyomes dont il faut se méfier (2017) (0)
Cartographier les ressources pour gérer les priorités (2019) (0)
Exposition des populations humaines au virus de l'immunodéficience simienne en Afrique : risque de nouvelles transmission inter-espèces (2005) (0)
La pathologie cutanée des baignades en mer métropolitaine (1993) (0)
Quand et pourquoi doser les anticorps anti-cytoplasme des polynucléaires neutrophiles (ANCA) en dermatologie? (1995) (0)
CAS CLINIQUE D'UN MAL PERFORANT PLANTAIRE CHRONIQUE GUÉRI PAR GREFFE DE PEAU MINCE (2011) (0)
Pelade induite par le mogamulizumab : un effet indésirable de bon pronostic sur la maladie ? (2021) (0)
L'aplasie médullaire : une complication tardive de la dyskératose congénitale (1998) (0)
P317 - Pyoderma gangrenosum facial et rectocolite hémorragique (2005) (0)
Des lésions récidivantes (2017) (0)
Prise de poids sous infliximab : étude rétrospective à propos de 35 malades (2011) (0)
Autoévaluations de l'article : Manifestations cutanéomuqueuses des affections hépatobiliaires et pancréatiques (2011) (0)
Foie et voies biliaires (2012) (0)
Manifestations cutanéomuqueuses des affections hépatobiliaires et pancréatiques (2004) (0)
Les outils thérapeutiques de l’angiome plan. Réponses au pré-test (2013) (0)
Les folliculites pustuleuses à éosinophiles (2000) (0)
Multiplex serological investigation of antibodies against Ebola viruses in a large panel of African bat species (2017) (0)
Éducation thérapeutique du patient et dermatoses chroniques en médecine générale (2013) (0)
ANALYSIS OF THE SIMIAN ORIGIN OF THE HTLV-I SUBTYPES (1999) (0)
Sarcoïdose sous-cutanée atypique (2002) (0)
Efficacité de la photophérèse dans un cas de maladie de Crohn cutanée sévère (2014) (0)
Blessures par projectiles de paintball : revue de la littérature. À propos de deux cas (2011) (0)
Effet secondaire cutané du bévacizumab : nécroses cutanées localisées sur des vergetures cortico-induites chez un homme traité pour un glioblastome (2014) (0)
La surexpression lymphocytaire du récepteur ICOS au sein d’un infiltrat cutané permet la distinction entre une érythrodermie inflammatoire et un syndrome de Sézary (2022) (0)
Une association exceptionnelle : dermatomyosite et mucinose papuleuse primitive (2000) (0)
Journées dermatologiques de Paris 2018 (2018) (0)
Nodule de maladie de Kaposi unique situé sur la nuque d’un patient immunocompétent (2022) (0)
Revue De La Littérature (1994) (0)
COL 8-05 - Séquelles liées au virus Ebola : résultats de la cohorte Postebogui (2016) (0)
Mortalité du pemphigus et facteurs pronostiques, incluant les traitements initialement proposés (2018) (0)
Indications et modalités du traitement par le zinc en dermatologie (1989) (0)
Syndrome du flush gustatif (2022) (0)
Étude randomisée évaluant l’efficacité et la tolérance du rituximab associé à une corticothérapie allégée par rapport à une corticothérapie standard dans le traitement du pemphigus☆ (2015) (0)
Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa? (1998) (0)
L'éosinophile : données fondamentales (2000) (0)
Endocardite à Bacillus cereus : une cause rare d’endocardite, une porte d’entrée inhabituelle☆ (2015) (0)
Herpès Zoster. Epidémiologie, physiopathologie, diagnostic, évolution et pronostic (1989) (0)
Étude randomisée en double aveugle contre placebo évaluant l’efficacité du méthotrexate seul ou associé à une faible corticothérapie générale dans les formes sévères de pelade (totales/universelles) d’évolution chronique (2019) (0)
Cas anatomoclinique de maladie de Woringer et Kolopp Intérêt de l'étude immunohistochimique (2000) (0)
Prevalence of Hepatitis C Virus Antibodies Among Pregnant Women and Blood Donors in Benin (1995) (0)
Affections du tube digestif (2008) (0)
Un nodule de l'oreille (1995) (0)
Reproductibilité inter-observateur des scores de sévérité du pemphigus ABSIS et PDAI (2015) (0)
Iconography : Affections du tube digestif (2008) (0)
Alopécie androgénétique de la femme : Une réponse thérapeutique rapide est nécessaire (1996) (0)
Comparaison de l’évolution de la qualité de vie sous traitement des patients atteints de pemphigoïde bulleuse, pemphigoïde cicatricielle ou pemphigus (2020) (0)
Traitement par photochimiothérapie extracorporelle de 7 cas de dermatite atopique sévère de l’adulte (2015) (0)
Pourquoi une même dermatose stéréotypée (exemple: le pyoderma gangrenosum) peut-elle avoir des causes si différentes ? (1997) (0)
Une complication transitoire méconnue du laser CO2 dans la maladie de Hailey-Hailey (2014) (0)
Assessment of Infections with Microsporidia and Cryptosporidium spp. in Fecal Samples from Wild Primate Populations from Cameroon and Democratic Republic of Congo (2015) (0)
Carcinome adénoïde kystique primitivement cutané développé sur radiodermite chronique (2021) (0)
Lupus miliaire de la face. Six observations (2003) (0)
Trop de peau, pas de sang ! (2000) (0)
Pemphigus profond radio induit (2013) (0)
Efficacité et tolérance à long terme des schémas thérapeutiques testés chez les patients atteints de pemphigus inclus dans l’essai clinique Ritux 3 (2022) (0)
Histiocytose mucineuse progressive héréditaire : à propos de 2 cas☆ (2016) (0)
Nodule d’Orf : second génome viral décrit et séquencé chez l’homme (2018) (0)
Iconography : Nodule du visage (2008) (0)
Nodules érythémateux des mains et ramadan. Réponse (1996) (0)
Syndrome d’ichtyose du prématuré (2013) (0)
Hidradénite neutrophilique eccrine induite par le bortezomib (Velcade (2012) (0)
Apparition de novo d'un rhumatisme psoriasique chez des patients traités par Efalizumab pour un psoriasis cutané : un effet secondaire inattendu d'une nouvelle biothérapie dans le psoriasis (2007) (0)
Comparative immuno-virological and clinical responses to antiretroviral therapy between HIV-1 group O- and HIV-1 group M-infected patients (ANRS 12168 DynaMO study). (2019) (0)
Le Bonobo : Origine des HTLV mais pas du VIH (2013) (0)
Griffure de chat et tuméfaction d'un doigt (2000) (0)
Psoriasis et syndrome métabolique: un lien physiopathologique ? (2014) (0)
Sclérodermie en plaques: efficacité remarquable du 1,25 dihydroxycholécalciférol (1993) (0)
Macrochéilite granulomateuse : efficacité des traitements systémiques dans une série rétrospective multicentrique de 61 patients (2020) (0)
A10 Presence and frequency of M184V mutation in the MOBIDIP trial (2019) (0)
Lésions psoriasiformes sévères du scalp induites par les anti-TNF alpha chez des patients traités pour une maladie inflammatoire chronique de l’intestin (MICI) : 18 cas☆ (2014) (0)
Implementation and evaluation of a therapeutic patient education programme during a clinical trial in Yaoundé, Cameroon - Trial ANRS-12286/MOBIDIP. (2018) (0)
Qualité de vie chez les patients atteints de pemphigus : corrélation avec le type et la sévérité du pemphigus (2013) (0)
Immunodeficiency Virus Phylogeny Insights into Simian / Human ) Provides New Cercopithecus nictitans from Greater Spot-Nosed Monkeys ( Gene vpu Immunodeficiency Virus with a Characterization of a Novel Simian (2002) (0)
Rémission rapide d’une urticaire au froid sévère sous omalizumab (Xolair) (2011) (0)
Corrélations entre les questionnaires de qualité de vie spécifiques aux maladies bulleuses auto-immunes ABQOL et TABQOL, et les scores de sévérité objectifs (2019) (0)
Un eczéma chronique: la dysidrose palmo-plantaire (1993) (0)
Un gros doigt pseudo-tumoral et des ulcérations buccales révélateurs d'une maladie de Crohn (1996) (0)
Assessment of gastrointestinal parasites in wild chimpanzees (Pan troglodytes troglodytes) in southeast Cameroon (2014) (0)
Étude du taux d’anticorps anti-BPAG2, mesuré par technique ELISA, comme biomarqueur des complications gravidiques au cours de la pemphigoïde de la grossesse (2020) (0)
Conduite à tenir devant une urticaire chronique (1996) (0)
Large Diffusion of Severe Acute Respiratory Syndrome Coronavirus 2 After the Successive Epidemiological Waves, Including Omicron, in Guinea and Cameroon: Implications for Vaccine Strategies (2023) (0)
Critères du Groupe Bulles national pour une facturation en hospitalisation de jour de la prise en charge d’un patient atteint de maladie bulleuse auto-immune (2016) (0)
Communication Correspondence (2003) (0)
[Seroprevalence of hepatitis C virus among persons visiting the Burundi health services]. (1995) (0)
Dynamics of Antibodies to Ebolaviruses in an Eidolon helvum Bat Colony in Cameroon (2022) (0)
TUMEUR ODDIENNE ASSOCIEE A UNE PEMPHIGOIDE (1995) (0)
HIV laboratory monitoring for effective ART in Africa – Authors' reply (2012) (0)
Un syndrome hyperéosinophilique avec mutation JAK2 (2013) (0)
Full Genome Characterization of a New Simian Immune Deficiency Virus Lineage in a Naturally Infected Cercopithecus ascanius whitesidei in the Democratic Republic of Congo Reveals High Genetic Diversity Among Red-Tailed Monkeys in Central and Eastern Africa. (2017) (0)
Traitement de la folliculite décalvante par PDT avec dispositifs lumineux textiles : à propos de 2 observations (2018) (0)
Journées dermatologiques de Paris 2017 (2017) (0)
Dermatophytose profonde à Microsporum canis chez un patient immunocompétent (2014) (0)
Manifestations cutanées révélatrices d’une leucémie monoblastique (2002) (0)
Granulomes pyogéniques récidivants (2018) (0)
Calcinose dystrophique et morphée (2021) (0)
Efficacité et devenir des greffes cutanées dans les angiodermites nécrotiques : à propos de 39 angiodermites nécrotiques (2013) (0)
Mutation originale du gène SCL39A4 dans le cadre d’une acrodermatite entéropathique de survenue tardive ☆ (2015) (0)
Réponse prolongée à l’infliximab : étude rétrospective multicentrique (2013) (0)
Définition des seuils de sévérité du pemphigus à partir des scores ABSIS et PDAI (2013) (0)
FRI0447 FIRST COMPREHENSIVE LONG-TERM ASSESSMENT OF MUSCULOSKELETAL CONSEQUENCES AMONG EBOLA SURVIVORS (2020) (0)
Global health. People, animals, plants, the environment: towards an integrated approach to health (2019) (0)
Traitement combiné des cicatrices hypertrophiques et chéloïdes par injection intra-lésionnelle et délivrance assistée par laser de corticostéroïdes (2019) (0)
Iconographies supplémentaires de l'article : Manifestations cutanéomuqueuses des affections hépatobiliaires et pancréatiques (2011) (0)
Correction: Susceptibility to Transmitting HIV in Patients Initiating Antiretroviral Therapy in Rural District Hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial) (2013) (0)
Parasite to Prevention: Advances in the understanding of malaria (2010) (0)
[Not Available]. (2016) (0)
Correction: Susceptibility to Transmitting HIV in Patients Initiating Antiretroviral Therapy in Rural District Hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial) (2013) (0)
Un érythème migrant très chronique (2018) (0)
Érythrodermie prolongée puis myocardite : mode de révélation inhabituel d'un syndrome hyperéosinophilique (2000) (0)
Iconographies supplémentaires de l'article : Peau et éosinophilie (2017) (0)
Analyse intermédiaire de l’efficacité du rituximab comme traitement de première intention du pemphigus (2013) (0)
Les anticorps monoclonaux chimériques anti-ICOS 314.8 inhibent les cellules tumorales et les lymphocytes T régulateurs dans le syndrome de Sézary (2022) (0)
Pancréatite aiguë alcoolique nécrotico-hémorragique avec signes de Grey Turner et de Cullen (2004) (0)
Les anticorps Anti – Saccharomyces cerevisiae sont un biomarqueur de l’hidrosadénite suppurée modérée à sévère mais pas du psoriasis en plaque sévère (2017) (0)
Propriétés antiélastasiques des propionylaminoacides (1991) (0)
Maladie de Rosai-Dorfman mimant une métastase cutanée de cancer du sein (2021) (0)
TO50 Syndrome douloureux régional complexe de type I et troubles factices (2007) (0)
Pyoderma gangrenosum avec localisations pulmonaires efficacement traité par l’infliximab (2011) (0)
431 - Cinétique de la réponse humorale en anticorps contre la maladie à virus Ebola en Guinée (2022) (0)
Operational research and HIV policy and guidelines: Lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon (2012) (0)
Une pemphigoïde atypique (2011) (0)
[Present status of HIV infection in Sub-Saharan Africa]. (1999) (0)
Association d’un psoriasis pustuleux généralisé à une érythrodermie ichtyosiforme congénitale non bulleuse (2012) (0)
[HTLV-I and HTLV-II viruses: fifteen years after their description]. (1995) (0)
Long term evolution of the clinical complications of Ebola virus disease : results of the Postebogui cohort (2017) (0)
Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials. (2022) (0)
Molecular characterization of a simian immunodeficiency virus lineage (SIVwrc) from western red colobus (Piliocolobus badius badius) (2007) (0)
La dermatite atopique des adultes de plus de 45 ans (2015) (0)
11-5 – Dermatoses éosinophiliques (2017) (0)
Vascularite induite par le sécukinumab chez une patiente traitée pour un rhumatisme psoriasique (2020) (0)
Pemphigoïde localisée prétibiale secondaire à un hématome cutané (2020) (0)
Laboratory monitoring for antiretroviral therapy in low-resource settings. (2013) (0)
HIV resistance to antiretroviral drugs in treated and treatment-naive patients in clinics using national guidelines for ART in the Democratic Republic of Congo (2009) (0)
Cost effectiveness evaluation of alternative monitoring strategies for antiretroviral therapy in low-resource settings : monitoring of HIV viral loads, CD4 cell counts and clinical assessments versus clinical monitoring alone (STRATALL ANRS 12110/ESTHER trial in Cameroon) (2012) (0)
Mieux comprendre l'origine des VIH (2008) (0)
L’espace et le temps pour travailler ensemble (2014) (0)
MYCOSIS FONGOIDE CHEZ UNE GABONAISE INFECTEE PAR LE HTLV-I (1996) (0)
Commercial Logging and HIV Epidemic, Rural (2004) (0)
Physiopathologie de la sarcoïdose. (1998) (0)
Anticoagulation régionale des circuits extracorporels par le citrate (2014) (0)
Les virus HTLV-I et HTLV-II: quinze ans après leur description (1995) (0)
Accès au traitement antirétroviral en Afrique: D'importantes difficultés en dépit de remarpuables progrès (2010) (0)
La gestion de la qualité des soins bucco-dentaires (1988) (0)
CO20 - Chimpanzés, réservoirs des formes pandémiques et non pandémiques du VIH-1 (2007) (0)
À propos d’un syndrome de Wells bulleux (2022) (0)
Science et développement durable : 75 ans de recherche au Sud (2019) (0)
Le syndrome d'immunodépression acquise (SIDA) au Gabon: A propos de 23 cas dans les services de médecine interne des centres hospitaliers de Libreville et de Franceville de 1985 à 1987 (1988) (0)
Quel rôle pathologique pour le virus de l'hépatite C (VHC) au Gabon ? : expérience du service de médecine interne du centre hospitalier de Libreville : résumé (2003) (0)
Projet SIDAK : rapport annuel 2000-2001 : publications 2000-2001 (2001) (0)
Comparative Immuno-Virological and Clinical Responses to Antiretroviral Therapy between HIV-1 Group O- and HIV-1 Group M-Infected Patients (ANRS 12168 DynaMO Study) (2018) (0)
Le rôle des médecins de ville dans un réseau de surveillance et d'alerte épidémique : l'exemple de Genève : Maladies infectieuses (2004) (0)
Epidémiologie phylogénétique : comprendre les origines des virus de l'immunodéficience humaine (VIH) et l'épidémie mondiale (2009) (0)
Veille et alerte sanitaire : la place des médecins de ville à Genève, Suisse (2005) (0)
Facteurs associés à une exérèse incomplète (EI) de carcinomes basocellulaires de la face et du cou (2021) (0)
Simian immunodeficiency virus infection in wildliving red colobus monkey (Piliocolobus badius badius) from the Taï forest, Côte D'Ivoire (2007) (0)
La carence sévère en zinc: Une cause d'érythème nécrolytique (2003) (0)
Pathologie associée au rétrovirus H.T.L.V. 1 dans un service de médecine interne à Libreville au Gabon (1989) (0)
Un cas de paraparésie spastique tropicale associée au HTLV1 en République du Niger. (1996) (0)
Actualites sur l'infection a VIH en Afrique sub-saharienne (1999) (0)
LSHTM Research Online (2020) (0)
[Not Available]. (2016) (0)
Les banques locales : des dépôts dans les banques (0)
Traitement des pyélonéphrites aiguës par la cefoxitine (1985) (0)
Prise de poids induite par le dolutegravir au Cameroun : suivi à 96 semaines de l’essai ANRS 12313 - NAMSAL (2020) (0)
Modélisation de l’évolution longitudinale des symptômes et de leurs prédicteurs chez les survivants de la maladie à virus Ebola en Guinée (2021) (0)
Hétéroplasie osseuse progressive atypique avec mutation du gene GNASI (2004) (0)
Hétérogénéité de la réponse en anticorps après infection par le virus Ebola en Guinée (2022) (0)
Eléphantiasis génital de la lymphogranulomatose vénérienne : deux observations djiboutiennes (1992) (0)
Les traitements minute en parasitologie (1985) (0)
Une uvéite antérieure aiguë induite par l’étanercept ? (2011) (0)
Phylogenetic characterization of STLV-I strains from various Asian and African monkey species (2001) (0)
Syphilis et anti-TNF alpha : une observation (2007) (0)
Autoévaluations de l'article : Peau et éosinophilie (2017) (0)
High HIV burden and recent transmission chains in rural forest areas in southern Cameroon, where ancestors of HIV-1 have been identified in ape populations. (2020) (0)
Effets indésirables cutanés retardés du natalizumab (2014) (0)
Syndrome de Sézary apparu sous anti-IL-5 (2021) (0)
Facteurs associés au choix du premier traitement biologique dans le psoriasis. Résultats de la cohorte nationale PsoBioTeq (2017) (0)
Quoi de neuf en thérapeutique dermatologique ? (2019) (0)
Un effet indésirable inhabituel du sorafénib (2014) (0)
Dermatoses neutrophiliques et maladie de Crohn (1991) (0)
Une complication rare du syndrome de Lyell (2013) (0)
A 40 months follow-up of Ebola virus disease survivors in Guinea (Postebogui) reveals long-term detection of Ebola viral Ribonucleic Acid in semen and breast milk (2020) (0)
Coronaviruses Are Abundant and Genetically Diverse in West and Central African Bats, including Viruses Closely Related to Human Coronaviruses (2023) (0)
Lésions cutanées à Mycobacterium kansasii chez un sujet immunocompétent (1993) (0)
Evidence of STLV-2 and STLV-3 infections in wild-living bonobos (P. paniscus ) from the Democratic Republic of Congo (2011) (0)
Étude prospective de prévalence des anticorps sériques anti Saccharomyces cerevisiae (ASCA) chez 71 patients atteints d’hidradénite suppurée (HS) (2012) (0)
Efficacité des anti-TNFα sur les atteintes cutanées de la sarcoïdose : étude multicentrique de 46 cas☆ (2016) (0)
Purpura vasculaire et abus de cocaïne : penser au lévamisole ☆ (2014) (0)
Manifestations cutanées de la sarcoïdose (1989) (0)
Ulcères et ulcérations de jambe d'origine hématologique (1996) (0)
Les autres dermatoses neutrophiliques (2000) (0)
De la condition du prodigue dans le droit romain, le droit français et les législations étrangères modernes (0)
Un effet secondaire parfois méconnu des biomédicaments (2015) (0)
Efficacité d’une troisième ligne de biomédicament dans le traitement du psoriasis sévère (2014) (0)
Prise en charge chirurgicale prcoce dune extravasation de carboplatine (2005) (0)
A second divergent 'STLV-L'-like strain detected in a Cercopithecus nictitans from Cameroon (2001) (0)
Tobacco smoking contributes to neutrophil activation in people living with HIV: the ACTIVIH study (2016) (0)
Efficacité des antipaludéens de synthèse dans l’urticaire retardée à la pression (2014) (0)
Dermohypodermite aiguë abdominale révélant une perforation grêlique (2014) (0)
Une cause rare de purpura vasculaire: la vascularite nécrosante cutanée récurrente hyperéosinophilique (1995) (0)
Malformation veineuse multifocale majeure à prédominance monomélique (1999) (0)
[Not Available]. (1991) (0)
Fièvres éruptives de l'enfant: le diagnostic doit être rapide et précis (1995) (0)
Iconography : Éruption nodulo-kystique induite par le sorafénib (2019) (0)
COL 8–04 - Complications ophtalmologiques de l’infection à virus Ebola (2016) (0)
Added Value of an Anti-Ebola Serology for the Management of Clinically Suspected Ebola Virus Disease Patients Discharged as Negative in an Epidemic Context (2022) (0)
Iconographies supplémentaires de l'article : Pemphigoïde du sujet jeune (2008) (0)
Les dermatoses éosinophiliques (2013) (0)
Pneumopathie interstitielle à l’infliximab : un effet indésirable grave à ne pas méconnaître (2015) (0)
Maladies rares digestives et dermatologiques (2012) (0)
Évaluation d’un questionnaire de sévérité au cours du pemphigus (2019) (0)
[An association of HIV infection and noma in Niger]. (2002) (0)
FACTEURS PRONOSTIQUES DU PEMPHIGUS PARANÉOPLASIQUE (2008) (0)
Les outils thérapeutiques de l’angiome plan. Pré-test (2013) (0)
Jusqu'ou faut-il aller dans le traitement des pelades graves? (1996) (0)
Lymphœdème pénien : une présentation inhabituelle d’hidrosadénite suppurée (2021) (0)
Interactions cellules épithéliales — système immunitaire (1991) (0)
Comparaison des coûts de santé du traitement de première ligne par rituximab par rapport à la corticothérapie standard chez les patients pemphigus nouvellement diagnostiqués (2018) (0)
Hyperpigmentation palmo-plantaire: un effet secondaire du cyclophosphamide mal connu (une observation) (1991) (0)
Caractéristiques des symptômes musculo-squelettiques observés chez les survivants du virus Ebola au sein de la cohorte Guinéenne Postebogui (2016) (0)
Évaluation de la trichoscopie dans le diagnostic de teigne, étude prospective multicentrique sur 2 ans, à propos de 100 patients (2018) (0)
Rôle du pharmacien d’officine dans la prise en charge de la dermatite atopique (2012) (0)
Une cryptococcose cutanée primitive à Cryptococcus albidus chez un malade diabétique (2012) (0)
Quand la toxidermie n’est pas limitée aux extrémités (2015) (0)
Psoriasis, dépression et anxiété (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Eric Delaporte?

Eric Delaporte is affiliated with the following schools:

Eric Delaporte's Academic­Influence.com Rankings

Eric Delaporte's Degrees

Similar Degrees You Can Earn

Why Is Eric Delaporte Influential?

Eric Delaporte's Published Works

Published Works

What Schools Are Affiliated With Eric Delaporte?

Eric Delaporte's AcademicInfluence.com Rankings